Cormorant Asset Management, LLC, 10% Owner, Director at PROTEOSTASIS THERAPEUTICS, INC. (PTI), bought 280,700 shares at $11.48 ($3.1M) on 2016-11-14, disclosed to the SEC on 2016-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.68 | 12,100 | $117K | 3.8% |
| 2 | $11.07 | 216,700 | $2.4M | 77.1% |
| 3 | $11.46 | 21,200 | $243K | 7.8% |
| 4 | $11.46 | 21,200 | $243K | 7.8% |
| 5 | $11.48 | 9,500 | $109K | 3.5% |
| Total | $11.08 avg | 280,700 |
| $3.1M |
| 100% |